II 117th CONGRESS 2d Session S. 3617 IN THE SENATE OF THE UNITED STATES February 9, 2022 Mrs. Blackburn introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation A BILL To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy and the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the Restoring Confidence to the World Anti-Doping Agency Act of 2022 . 2. Authority of the United States Anti-Doping Agency with respect to the World Anti-Doping Agency Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a)— (A) by amending paragraph (1) to read as follows: (1) United States Olympic and Paralympic Committee The term United States Olympic and Paralympic Committee means the organization established by chapter 2205 of title 36, United States Code. ; (B) by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order; and (C) by inserting after paragraph (2) the following: (3) Independent athlete The term independent athlete means an amateur athlete who does not serve, in any capacity, in— (A) the International Olympic Committee; (B) the International Paralympic Committee; (C) an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee; (D) the United States Olympic and Paralympic Committee; or (E) the World Anti-Doping Agency. ; (2) in subsection (b)— (A) by striking United States Olympic Committee each place it appears and inserting United States Olympic and Paralympic Committee ; (B) in paragraph (4), by striking the period at the end and inserting ; and ; and (C) by adding at the end the following: (5) carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (c). ; and (3) by adding at the end the following: (c) Authority with respect to the World Anti-Doping Agency (1) In general The Office of National Drug Control Policy, in conjunction with the United States Anti-Doping Agency, shall— (A) use all available tools to ensure that— (i) the World Anti-Doping Agency maintains a proper conflict-of-interest policy that prohibits an individual from serving as a member of the Executive Committee of the World Anti-Doping Agency if, during the preceding 2-year period, the individual served in any capacity for a sports federation that is or was under the jurisdiction of the World Anti-Doping Agency; and (ii) independent athletes from the United States and other democratic countries, or representatives of such athletes, have voting positions on the Executive Committee and governing bodies of the World Anti-Doping Agency, including the foundation board and all standing committees and working groups; (B) demonstrate leadership within the global community; (C) have strict standards that work toward countering the state-sponsored doping system of the Russian Federation and other state-sponsored, systemic fraud through doping; and (D) work collaboratively with democratic countries. (2) Determination (A) In general Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in conjunction with the United States Anti-Doping Agency, shall make a determination as to whether the World Anti-Doping Agency— (i) has a credible and independent governance model that provides for fair representation of the United States; (ii) maintains a conflict-of-interest policy described in paragraph (1)(A)(i); and (iii) allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have voting positions on the Executive Committee and governing bodies of the World Anti-Doping Agency, including the foundation board and all standing committees and working groups. (B) Accountability In the case of a determination under subparagraph (A) that the World Anti-Doping Agency does not have such a governance model, maintain such a conflict-of-interest policy, or allow such voting positions, the Office of National Drug Control Policy, in conjunction with the United States Anti-Doping Agency, shall— (i) submit a request to the Government Accountability Office to indicate the amount of United States taxpayer dollars used to pay dues to the World Anti-Doping Agency; (ii) demand that the United States have fair representation in World Anti-Doping Agency, including not fewer than one representative on each of— (I) the Executive Committee of the World Anti-Doping Agency; and (II) any other governing body of the World Anti-Doping Agency for which the United States pays dues; and (iii) issue a report that describes the justifications, and the countries responsible, for blocking the United States from the Executive Committee of the World Anti-Doping Agency. (3) United States participation in Executive Committee of the World Anti-Doping Agency (A) In general As a condition of United States participation in the World Anti-Doping Agency— (i) the United States shall be allotted not fewer than one seat on the Executive Committee of the World Anti-Doping Agency for as long as such Executive Committee is a representative body as structured on the date of the enactment of this subsection; and (ii) the World Anti-Doping Agency shall make a legal commitment to the Office of National Drug Control Policy and the United States Anti-Doping Agency that states there will be not fewer than one representative of the United States on such Executive Committee at all times. (B) Refund of dues If such Executive Committee appoints not fewer than one representative of the United States during the one-year period beginning on the date of the enactment of this subsection, the Office of National Drug Control Policy or the United States Anti-Doping Agency may not appeal to the World Anti-Doping Agency for a refund of dues paid during the period in which the United States did not have a representative on such Executive Committee. .